However, recent evidence has suggested that JNK may also act as a tumor suppressor in hepatocellular carcinoma [54], and stathmin inhibition of JNK may reduce this tumor suppressor effect as another mechanism by which stathmin acts as a tumor promoter. Here, MAPK8 is linked to hepatocellular carcinoma.